Key facts
- It has raised $63.5M; the latest was PE Growth/Expansion in Jan 2025.
- Notable investors include Carrick Capital Partners, Trinity Capital (Phoenix).
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Renalogic
- ·The full record, as it builds
Funding rounds
No funding rounds for Renalogic are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Renalogic
Provider of dialysis cost containment and renal risk management services intended for employer-based and other self-funded health plans. The company offers dialysis cost control, data analysis and risk prediction, kidney dialysis avoidance program and kidney disease prevention program, thereby helping clients save on their overall medical spending.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2002
- Employees
- 58
- Website
- renalogic.com/
- Ownership
- Privately Held (backing)
Renalogic doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Renalogic shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Renalogic in its N-PORT filings yet. We sweep new filings monthly.